Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mink Therapeutics Inc (NQ: INKT ) 0.7090 -0.0050 (-0.70%) Streaming Delayed Price Updated: 3:52 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mink Therapeutics Inc < Previous 1 2 3 4 Next > MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications February 06, 2024 Treatment with agenT-797 Showed Improved Survival in Severe Respiratory Distress From MiNK Therapeutics Via GlobeNewswire MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene January 30, 2024 From MiNK Therapeutics Via GlobeNewswire ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development December 20, 2023 From MiNK Therapeutics Via GlobeNewswire The Latest Analyst Ratings for MiNK Therapeutics May 12, 2023 Via Benzinga MiNK Therapeutics Reports Third Quarter 2023 Results November 09, 2023 From MiNK Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session November 03, 2023 Via Benzinga MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023 November 03, 2023 From MiNK Therapeutics Via GlobeNewswire MiNK to Provide Third Quarter 2023 Financial Report and Corporate Update October 30, 2023 From MiNK Therapeutics Via GlobeNewswire Recap: MiNK Therapeutics Q1 Earnings May 11, 2023 Via Benzinga Preview: MiNK Therapeutics's Earnings March 20, 2023 Via Benzinga Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying October 17, 2023 The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying October 09, 2023 The Dow Jones closed higher by around 290 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Intraday Session October 04, 2023 Via Benzinga MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023 September 27, 2023 From MiNK Therapeutics Via GlobeNewswire MiNK Therapeutics to Participate in September Investor Conferences August 24, 2023 From MiNK Therapeutics Via GlobeNewswire MiNK Therapeutics Reports Second Quarter 2023 Results August 10, 2023 From MiNK Therapeutics Via GlobeNewswire MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update July 28, 2023 From MiNK Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session June 22, 2023 Via Benzinga MiNK Therapeutics Announces Virtual Annual Shareholders Meeting June 05, 2023 From MiNK Therapeutics Via GlobeNewswire MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference May 22, 2023 From MiNK Therapeutics Via GlobeNewswire MiNK's Novel FAP-CAR-iNKT Presented at ASGCT May 18, 2023 From MiNK Therapeutics Via GlobeNewswire Over $1M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying May 15, 2023 The Dow Jones closed slightly lower on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... Via Benzinga MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results May 11, 2023 From MiNK Therapeutics Via GlobeNewswire First Foundation And 2 Other Penny Stocks Insiders Are Aggressively Buying May 05, 2023 The Dow Jones closed lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 04, 2023 Via Benzinga MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results April 27, 2023 From MiNK Therapeutics Via GlobeNewswire MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting April 18, 2023 From MiNK Therapeutics Via GlobeNewswire Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics March 30, 2023 From Agenus Inc. Via Business Wire MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results March 21, 2023 From MiNK Therapeutics Via GlobeNewswire Earnings Scheduled For March 21, 2023 March 21, 2023 Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
